Univariate analysis found that tumor stage, grade, LVI status, multifocal status, HER2 status, and Ki67 expression level were significantly different between patients with 1–2 positive ALNs and ≥ 3 positive ALNs (P <  0.05). This evidence concerns the gene ERBB2 and neoplasm.